Medical Innovation Exchange

Theranos Founder Sentenced to 11 Years in Prison



November 18, San Jose, CA: Theranos founder Elizabeth Holmes has been sentenced to 135 months (11.25 years) in prison by U.S. District Judge Edward Davila.

Holmes, who was found guilty in January on three counts of investor fraud and one count of conspiracy to commit fraud related to her blood-testing startup, faced up to 20 years in prison for each guilty count. Her sentence will begin on April 27, 2023.

Prosecutors asked for a 15-year sentence. Holme’s defense team sought no more than 18 months in prison. Per reporter Ethan Baron, who covered the sentencing live on his Twitter feed, Judge Davila declined to consider patient harm in the sentencing, as Holmes was acquitted of all charges related to patient harm, nor did he consider the full investor losses of $700 million, stating that there was “insufficient evidence to show that the defendant’s fraud and conspiracy was the sole cause of the company’s collapse.”

He instead based the sentence on Holmes defrauding 10 or more victims for a loss of $121 million.

Ramesh “Sunny” Balwani, former president and chief operating officer of Theranos, who was found guilty on 12 counts of fraud earlier this year, is scheduled to be sentenced next month.

Related Articles

  • gavel

    There are also reports that Elizabeth Holmes, as part of her defense, may argue ex-boyfriend and former Theranos President Sunny Balwani abused her during their relationship.

  • The company is eliminating 155 positions.

  • Data, Cybersecurity, healthcare

    URGENT/11 introduces risks to medical device and hospital networks, and could allow a remote attacker to take control of a medical device such as an anesthesia machine of insulin pump.

  • Finger prick lab tests, Theranos

    There are concerns over the accuracy of direct-to-consumer tests.


Original post:

Post publish date:


Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!